生物活性 | |||
---|---|---|---|
描述 | Chonglou Saponin VII (Paris saponin VII, PSVII) is a steroidal saponin isolated from the roots and rhizomes of Trillium tschonoskii Maxim. PSVII (Paris saponin VII) could inhibit the growth of adriamycin-resistant human leukemia cells (K562/ADR) in a dose-dependent manner. PSVII significantly suppressed cell proliferation by cell cycle arrest in the G0/G1 phase. Moreover, PSVII could attenuate mitochondrial membrane potential, increase the expression of apoptosis-related proteins, such as Bax and cytochrome c, and decrease the protein expression levels of Bcl-2, caspase-9, caspase-3, PARP-1, and p-Akt. PSVII induced a robust autophagy in K562/ADR cells[2]. The half maximal inhibitory concentration (IC50) value of PS VII for the growth inhibition of Hela cells was 2.62 ± 0.11 μM[3]. Treatment with PSVII influenced cell viability of MCF-7/ADR cells, as well as sensitized MCF-7/ADR cells to the cytotoxic effects of adriamycin. Moreover, PSVII significantly downregulated MDR1 (multidrug-resistant) expression in MCF-7/ADR cells. Intravenous administration of PSVII significantly enhanced anticancer efficacy of adriamycin to MCF-7/ADR xenograft model in nude mice[4]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
0.97mL 0.19mL 0.10mL |
4.85mL 0.97mL 0.48mL |
9.70mL 1.94mL 0.97mL |
参考文献 |
---|